These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 12881707

  • 1. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.
    Oncogene; 2003 Jul 17; 22(29):4509-16. PubMed ID: 12881707
    [Abstract] [Full Text] [Related]

  • 2. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 17; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 3. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK, Mitra S.
    Carcinogenesis; 2003 Aug 17; 24(8):1337-45. PubMed ID: 12807730
    [Abstract] [Full Text] [Related]

  • 4. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
    Gao J, Chen T, Liu J, Liu W, Hu G, Guo X, Yin B, Gong Y, Zhao J, Qiang B, Yuan J, Peng X.
    Glia; 2009 Jul 17; 57(9):989-99. PubMed ID: 19062177
    [Abstract] [Full Text] [Related]

  • 5. Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.
    Hubé F, Reverdiau P, Iochmann S, Rollin J, Cherpi-Antar C, Gruel Y.
    Biol Chem; 2003 Jul 17; 384(7):1029-34. PubMed ID: 12956419
    [Abstract] [Full Text] [Related]

  • 6. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
    Konduri SD, Osman FA, Rao CN, Srinivas H, Yanamandra N, Tasiou A, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Kouraklis G, Rao JS.
    Oncogene; 2002 Jan 31; 21(6):921-8. PubMed ID: 11840337
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 8. Identification of a genomic fragment that directs hematopoietic-specific expression of Rac2 and analysis of the DNA methylation profile of the gene locus.
    Ladd PD, Butler JS, Skalnik DG.
    Gene; 2004 Oct 27; 341():323-33. PubMed ID: 15474314
    [Abstract] [Full Text] [Related]

  • 9. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.
    Grassi G, Maccaroni P, Meyer R, Kaiser H, D'Ambrosio E, Pascale E, Grassi M, Kuhn A, Di Nardo P, Kandolf R, Küpper JH.
    Carcinogenesis; 2003 Oct 27; 24(10):1625-35. PubMed ID: 12869421
    [Abstract] [Full Text] [Related]

  • 10. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN, Lakka SS, Kin Y, Konduri SD, Fuller GN, Mohanam S, Rao JS.
    Clin Cancer Res; 2001 Mar 27; 7(3):570-6. PubMed ID: 11297250
    [Abstract] [Full Text] [Related]

  • 11. Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells.
    Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Rao JS.
    Int J Oncol; 2003 Jun 27; 22(6):1277-83. PubMed ID: 12738994
    [Abstract] [Full Text] [Related]

  • 12. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
    Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE.
    Science; 2003 Oct 31; 302(5646):890-3. PubMed ID: 14593184
    [Abstract] [Full Text] [Related]

  • 13. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.
    J Biochem; 2005 Mar 31; 137(3):431-40. PubMed ID: 15809347
    [Abstract] [Full Text] [Related]

  • 14. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N, Seuter S, Schnur N, Jung M, Steinhilber D.
    Biol Chem; 2003 May 31; 384(5):777-85. PubMed ID: 12817474
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C, Song JZ, Davidson B, Clark SJ.
    Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.